To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: Canasa (Mesalamine) Suppositories For Active Ulcerative Proctitis Now Available In the US URL: http://www.pslgroup.com/dg/1F84F2.htm Doctor's Guide April 18, 2001
MONT SAINT-HILAIRE, QC -- April 18, 2001 -- Axcan Phama Inc. announced it has commenced marketing of Canasa 500 mg mesalamine (5-ASA) rectal suppositories in the United States. These suppositories, indicated for the treatment of active ulcerative proctitis, are marketed through Axcan's own specialized sales and marketing organization comprised of 77 field sales representatives in the United States. The total market for mesalamine suppositories was approximately US$22 million in fiscal 1999. "This is great news for patients suffering from active ulcerative proctitis since these suppositories could induce a rapid remission of their disease and an improved quality of life," commented Léon F. Gosselin, Axcan's President and CEO. "We are confident in our ability to serve a large portion of patients treated with mesalamine since this product fits perfectly into our gastroenterology expertise," he concluded. Since August 1999, at the request of the Food and Drug Administration, Axcan has been selling these suppositories in the United States under a temporary, emergency measure due to the lack of any other source of supply. Subsequently, Axcan successfully accelerated completion of preclinical and clinical studies and then filed an NDA on April 28, 2000, which review was expedited and led to approval on January 4, 2001. SOURCE: Axcan Pharma Inc. --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.